Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma

Cancer

Volumn 103, Issue 10, 2005, Pages 2181-2188

  Liang, Shi Xiong ^a   Zhu, Xiao Dong ^a   Lu, Hai Jie ^a   Pan, Chao Yang ^a   Li, Fu Xiang ^a   Huang, Qi Fang ^a   Wang, An Yu ^a   Chen, Long ^a   Fu, Xiao Long ^b   Jiang, Guo Liang ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

3 dimensional conformal radiation therapy; Hypofractionation; Primary liver carcinoma

Indexed keywords

ANALGESIC AGENT; CAMPTOTHECIN DERIVATIVE; CISPLATIN; DEXAMETHASONE; EPIRUBICIN; GELFOAM; IODINATED POPPYSEED OIL; MANNITOL; MITOMYCIN C;

ABDOMINAL PAIN; ADULT; AGED; APPETITE DISORDER; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPUTER ASSISTED RADIOTHERAPY; FATIGUE; FEMALE; FOLLOW UP; GASTROENTERITIS; GASTROINTESTINAL HEMORRHAGE; HUMAN; INOPERABLE CANCER; LEUKOPENIA; LIVER CARCINOMA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHOTON; PRIORITY JOURNAL; RADIATION DOSE; REGRESSION ANALYSIS; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOEMBOLIZATION, THERAPEUTIC; DISEASE PROGRESSION; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; GASTROENTERITIS; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY, CONFORMAL; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 18044379522     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21012     Document Type: Article

References (19)

1. Skolnick AA. Armed with epidemiologic research, China launches programs to prevent liver cancer. JAMA 1996;276:1458-1459.
2. Guyton KZ, Kensler TW. Prevention of liver cancer. Curr Opin Oncol. 1997;9:492-496.
3. Li L, Lu F, Zhang S. [Analyses of variation trend and short-term detection of Chinese malignant tumor mortality during twenty years]. Zhonghua Zhong Liu Za Zhi. 1997;19:3-9.
4. Cheng JC, Chuang VP, Cheng SH, et al. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2000;47:435-442.
5. Ikeda K, Kumada H, Saitoh S, et al. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model. Cancer. 1991;68:2150-2154.
6. Stillwagon GB, Order SE, Guse C, et al. 194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a Radiation Therapy Oncology Group Study. Int J Radiat Oncol Biol Phys. 1989;17:1223-1229.
7. Matsuura M, Nakajima N, Arai K, et al. The usefulness of radiation therapy for hepatocellular carcinoma. Hepatogastroenterology. 1998;45:791-796.
8. Seong J, Keum KC, Han KH, et al. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 1999;43:393-397.
9. Seong J, Park HC, Han KH, et al. Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys. 2000;47:1331-1335.
10. Lawrence TS, Robertson JM, Anscher MS, et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys. 1995;31:1237-1248.
11. Lawrence TS, Tesser RJ, ten Haken RK. An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy. Int J Radiat Oncol Biol Phys. 1990;19:1041-1047.
12. Dawson LA, McGinn CJ, Normolle D, et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol. 2000;18:2210-2218.
13. Robertson JM, Lawrence TS, Dworzanin LM, et al. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol. 1993;11:1286-1293.
14. Herfarth KK, Debus J, Lohr F, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol. 2001;19:164-170.
15. Yang BH. Primary liver cancer. In: Chinese Anti-Cancer Association, editor. Guidelines for common cancers in China. Chinese Union Medical University: Beijing. 1999. pp389-479.
16. Lawrence TS, ten Haken RK, Kessler ML, et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys. 1992;23:781-788.
17. th Annual Meeting of the American Society of Therapeutic Radiology and Oncology, Atlanta, USA, Oct. 4-6, 2004.
18. th National Conference on Primary Liver Cancer. Shanghai. 1981. p 17.
19. Schoniger-Hekele M, Muller C, Kutilek M, et al. Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut. 2001;48:103-109.